Cancer News and Research

Latest Cancer News and Research

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

Self-sampling followed by HPV testing can benefit women at risk of cervical cancer

Using self-sampling followed by HPV testing, more than twice as many women at risk of developing cervical cancer could be identified and offered preventive treatment.

16 Feb 2018

Research identifies gene variants that play key role in how ovarian cancer patients process chemotherapy

Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

16 Feb 2018

Stem cell vaccine helps protect mice against numerous cancers, finds study

Lab mice injected with inactivated induced pluripotent stem cells (iPSCs) displayed a significant immune response against lung, breast, and skin cancers. The vaccine also prevented relapses in animals with removed tumors.

16 Feb 2018

Gene editing tool used to detect cancer

Researchers have developed a DNA detection system that can detect the presence of bacterial and viral DNA, which could be a valuable diagnostic tool for a range of disorders.

16 Feb 2018

US-based clinical study highlights safety and effectiveness of MENTOR MemoryShape Gel Breast Implants

Mentor Worldwide LLC, a global leader in breast aesthetics and part of the Johnson & Johnson Medical Devices companies, announced today the Plastic and Reconstructive Surgery publication of a U.S.-based 10-year clinical study involving 955 patients which highlights the safety of MENTOR MemoryShape Gel Breast Implants.

16 Feb 2018

Fathers maybe passing on ovarian cancer genes to their daughters

According to a team of researchers from the Roswell Park Cancer Institute, a new gene mutation could be responsible for ovarian cancers and this could be passed on from fathers to their daughters.

16 Feb 2018

Ultra-processed foods linked to increased risk of cancers

A new study by French researchers links ultra-processed food consumption and cancer. Ultra-processed foods include mass produced chicken and fish nuggets, meatballs, breads, buns, crisps, chocolates, sweets, cakes, instant noodles and soups, frozen and ready to eat meals, sodas, sweetened drinks etc.

16 Feb 2018

Inert gas may limit blast-induced brain injury

The inert gas has been used for the first time to try and reduce the impact of traumatic brain injuries (TBI) caused by blasts such as those in conflict zones and terror attacks.

15 Feb 2018

Study reveals the association between ultra-processed foods and cancer

Researchers in Brazil and France have discovered the possible correlations between the intake of highly processed foods and risk of overall cancer, including prostate, breast, and bowel (colorectal) cancers.

15 Feb 2018

New guidelines offer recommendations for assessment, management of immunotherapy side effects

Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different types of cancer. By unleashing the body's immune system to attack cancer, these treatments can send even the most hard-to-treat cancers into lasting remission.

15 Feb 2018

UTA professor wins grant to study link between fat storage in the heart and cardiovascular disease

Michael Nelson, assistant professor of kinesiology at The University of Texas at Arlington, has received a new five-year, $3.3 million grant from the National Institutes of Health to study the link between fat storage in the heart and cardiovascular disease, as well as the influence of gender on the development of cardiac dysfunction.

15 Feb 2018

New NK cell-based immunotherapy effective against several types of leukemia

Researchers at Karolinska Institutet in Sweden have explored NK cell-based immunotherapy on patients with treatment-resistant leukemia. The study, which is published in the scientific journal Clinical Cancer Research, shows that the new therapy is effective against several types of leukemia.

15 Feb 2018

Potential new principle for treatment of multiple forms of cancer

A study published in Science Translational Medicine shows that small molecules that specifically inhibit an important selenium-containing enzyme may be useful in combating cancer. When researchers at Karolinska Institutet treated cancer in mice using these molecules, they observed rapid tumoricidal effects.

15 Feb 2018

Researchers detail molecular atlas of cells that form brain's blood vessels

Even though diseases of the brain vasculature are some of the most common causes of death in the West, knowledge of these blood vessels is limited.

15 Feb 2018

Cervical tumors may be vulnerable to therapies that attack cancer's fuel supply, study shows

Cancer therapies have improved -- in some cases dramatically -- over the past two decades, but treatment for cervical cancer has remained largely unchanged. All patients receive radiation and chemotherapy, yet despite the aggressive approach, the regimen fails in about one-third of patients with cervical cancer that has spread beyond the cervix but not outside the pelvis.

15 Feb 2018

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.

15 Feb 2018